Bladder Cancer Adjuvant Radiotherapy Trial (BART)
Prospective Randomized Trial of Adjuvant Radiotherapy Following Surgery and Chemotherapy in Muscle Invasive Transitional Cell Carcinoma of Urinary Bladder
Sponsor: Tata Memorial Centre
This PHASE3 trial investigates Bladder Cancer and Urothelial Carcinoma Bladder and is currently ongoing. Tata Memorial Centre leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Mar 2025 — Present [monthly]
Active Not Recruiting PHASE3
Status: Unknown → Active Not Recruiting · Phase: NA → PHASE3
-
Sep 2024 — Mar 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Nov 2021 — Nov 2023 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Recruiting NA
-
Oct 2019 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2018 — Oct 2019 [monthly]
Recruiting NA
Phase: PHASE3 → NA
-
Aug 2018 — Oct 2018 [monthly]
Recruiting PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tata Memorial Centre
For direct contact, visit the study record on ClinicalTrials.gov .